Impact of Neuropsychological Disorders in Multiple Sclerosis

Summary

The study involves MS patients with and without neuropsychological disorders. The patient will benefit from: * A routine neuropsychological assessment, including a cognitive and emotional assessment * A clinical examination * A three-dimensional analysis of movement

Eligibility

Inclusion Criteria:

* Understanding and able to speak French
* Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS \<4
* No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS \<2)
* Absence of corticosteroid intake in the last four weeks
* Benefiting from health insurance coverage
* Not showing any flare-ups or worsening of the disease in the last 6 weeks
* No botulinum toxin injection for more than 4 months

Exclusion Criteria:

* People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
* Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
* Refusal to participate after clear and fair information about the study.
* Adults under tutorship, curatorship or safeguard of justice
* With orthopedic treatment influencing walking
* Pregnant woman

Conditions1

Browse More Trials